• 15 Hits
  • 検索条件 : 絞込み (MeSH = Osteosarcoma / therapy*)
生物種 リソース名 タイトル
ヒト・動物細胞 LM8(RCB1450) Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
ヒト・動物細胞 LM8(RCB1450) Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.
ヒト・動物細胞 HOS(RCB0992) , MG-63(RCB1890) , Saos-2(RCB0428) Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.
ヒト・動物細胞 HOS(RCB0992) Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells.
ヒト・動物細胞 LM8(RCB1450) Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
ヒト・動物細胞 LM8(RCB1450) Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody.
ヒト・動物細胞 HOS(RCB0992) , MG-63(RCB1890) , Saos-2(RCB0428) Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors.
ヒト・動物細胞 LM8(RCB1450) Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
ヒト・動物細胞 143B/TK^(-)neo^(R)(RCB0701) , Saos-2(RCB0426) , HOS(RCB0992) Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.
ヒト・動物細胞 NOS-1(RCB1032) Midkine as a novel target for antibody therapy in osteosarcoma.
ヒト・動物細胞 NOS-1(RCB1032) Smoothened as a new therapeutic target for human osteosarcoma.
ヒト・動物細胞 LM8(RCB1450) Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.
ヒト・動物細胞 HOS(RCB0992) Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells.
ヒト・動物細胞 HeLa(RCB0007) Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus.
ヒト・動物細胞 HS-Os-1(RCB2229) , NOS-1(RCB1032) , HuO-3N1(RCB2104) Functional genome screen for therapeutic targets of osteosarcoma.